Care

How Does the FDA Expansion of Anktiva Impact Bladder Cancer?
Care How Does the FDA Expansion of Anktiva Impact Bladder Cancer?

By activating both natural killer cells and T-cells, Anktiva creates a targeted immune environment that helps preserve the bladder while effectively managing aggressive urothelial carcinoma. This specialized immunotherapy represents a critical evolution in the treatment of non–muscle-invasive b

Why Are Your Prescription Quantities Being Limited?
Care Why Are Your Prescription Quantities Being Limited?

Manufacturing complications and quality control failures identified by the FDA are frequently the underlying causes for sudden medication shortages across the United States. In the current landscape of 2026, the transition from a system of pharmaceutical abundance to one defined by frequent supply

ECP Prepares Hospitals for New CMS Emergency Care Standards
Care ECP Prepares Hospitals for New CMS Emergency Care Standards

The grace period for hospital inefficiency is closing as the 2027 deadline for mandatory emergency department performance reporting rapidly approaches. For years, the internal operational data of emergency rooms remained largely shielded from public scrutiny, but a major regulatory shift is now

How Is Singapore Reforming Its Mental Healthcare System?
Care How Is Singapore Reforming Its Mental Healthcare System?

New ethical guidelines from the Singapore Medical Council are being revised to allow doctors to prioritize a minor's best interests when providing psychiatric care. This pivotal change represents a significant shift in the national strategy to address the growing psychological needs of the

Derriford Hospital Ranked Worst A&E in England for Eight Months
Care Derriford Hospital Ranked Worst A&E in England for Eight Months

Derriford Hospital's performance is currently the most extreme example of a regional decline in emergency care standards that affects multiple counties in the South West. For the eighth consecutive month, the facility has found itself at the bottom of national rankings, highlighting a

Roche Expands Obesity Pipeline With $2.1 Billion RNAi Deal
Care Roche Expands Obesity Pipeline With $2.1 Billion RNAi Deal

Faisal Zain has spent decades at the intersection of medical technology and biopharmaceutical innovation, watching the industry pivot from broad-spectrum treatments to the surgical precision of genetic medicine. As a recognized authority on medical device manufacturing and diagnostic evolution, he

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later